CIK 0001388320 · Non-accelerated filer<br>Smaller reporting company
Actinium Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ATNM
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880378336
- Phone
- (646) 677-3870
- Business address
- 100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
- Former names
- Cactus Ventures, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-05-06 | Memorial Sloan-Kettering Cancer Center 10% owner | Other acquisition | +5,702,387 | 5,702,387 | ||
| 2015-02-18 | CICIC DRAGAN COO and Chief Medical Officer | Grant or award · Options to purchase common stock | +35,000 | $3.58 | $125K | 35,000 |
| 2015-02-18 | TRAVERSA SERGIO Director | Grant or award · Options to purchase common stock | +25,000 | $3.58 | $90K | 25,000 |
| 2015-02-18 | Steinhart Richard I Director | Grant or award · Options to purchase common stock | +25,000 | $3.58 | $90K | 25,000 |
| 2015-02-18 | DAVE KAUSHIK J President, CEO and Interim CFO | Grant or award · Options to purchase common stock | +150,000 | $3.58 | $537K | 150,000 |
| 2014-09-23 | SETH SANDESH Executive Chairman | Grant or award · Options | +150,000 | $3.58 | $537K | 150,000 |
| 2014-09-23 | SETH SANDESH Director | Grant or award · Options | +280,000 | $6.13 | $1.7M | 204,853 |
| 2014-02-21 | CICIC DRAGAN COO and Chief Medical Officer | Grant or award | +3,500 | $5.55 | $19K | 3,500 |
| 2014-02-21 | CICIC DRAGAN COO and Chief Medical Officer | Grant or award · Options to purchase common stock | +31,500 | $5.55 | $175K | 31,500 |
| 2013-12-16 | Steinhart Richard I Director | Grant or award · Options to purchase common stock | +49,950 | $6.70 | $335K | 49,950 |
| 2013-12-16 | DAVE KAUSHIK J President and CEO | Grant or award · Options to purchase common stock | +675,000 | $6.70 | $4.5M | 675,000 |
| 2013-08-08 | SETH SANDESH Director | Grant or award | +10,000 | $3.60 | $36K | 0 |
| 2013-08-08 | TRAVERSA SERGIO Interim CFO | Grant or award | +10,000 | $3.60 | $36K | 0 |
| 2013-08-08 | TRAVERSA SERGIO Interim CFO | Grant or award · Options to purchase common stock | +20,000 | $3.60 | $72K | 4,995 |
| 2013-07-25 | SETH SANDESH Director | Other acquisition · Common Stock Purchase Warrant | +721,068 | $0.01 | $7K | 178,350 |
| 2013-05-15 | MAZANET ROSEMARY Director | Purchase | +100 | $3.95 | $395 | 100 |
Page 16 of 16 · 316 trades